Clinical Microbiology Reviews

(The H4-Index of Clinical Microbiology Reviews is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Antimicrobial Resistance in ESKAPE Pathogens684
Coronavirus Disease 2019–COVID-19605
Aspergillus fumigatus and Aspergillosis in 2019424
Epidemiology of β-Lactamase-Producing Pathogens352
The Global Ascendency of OXA-48-Type Carbapenemases221
Emerging Tick-Borne Diseases199
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy185
New β-Lactam–β-Lactamase Inhibitor Combinations184
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection155
Remdesivir against COVID-19 and Other Viral Diseases154
Chagas Disease in the United States: a Public Health Approach128
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection120
Laboratory Diagnosis of Human Brucellosis110
Antifungal Susceptibility Testing: Current Approaches103
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis92
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders87
Host-Directed Antiviral Therapy83
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory83
Convalescent Plasma Therapy for COVID-19: State of the Art82
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries82
Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem82
Human Melioidosis81
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria77
Yersinia pestis: the Natural History of Plague68
Microsporidiosis in Humans65
Pathogenesis of Gram-Negative Bacteremia63
Tuberculosis Vaccine Development: Progress in Clinical Evaluation58
Viral Respiratory Pathogens and Lung Injury56
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies53
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis53
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and52
Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters52
Evolutionary Pathways and Trajectories in Antibiotic Resistance51
Laboratory Diagnosis of Lyme Borreliosis50
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis50
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products50
Advances in the Microbiology of Stenotrophomonas maltophilia48
Intrathecal Antibacterial and Antifungal Therapies45
SARS-CoV-2 Antiviral Therapy45
Pathogenesis of Respiratory Viral and Fungal Coinfections43
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes43
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries43
Taenia solium Cysticercosis and Its Impact in Neurological Disease42